Eci Pharmaceuticals, LLC
Records under this name other than the patents Eci Pharmaceuticals, LLC holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 1 patents it holds.
Showing 1 to 8 of 8 · Back to Eci Pharmaceuticals, LLC
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 11,452,690 | Oral Liquid Compositions Comprising Amlodipine Besylate and Methods of Using the Same Lapsed on the fee record Ended Sep 27, 2026 · High confidence | Lapsed on the fee record | Ended Sep 27, 2026 | High confidence |
| US 11,446,243 | Oral Liquid Compositions Including Valsartan Lapsed on the fee record Ended Sep 20, 2026 · High confidence | Lapsed on the fee record | Ended Sep 20, 2026 | High confidence |
| US 11,202,766 | Pharmaceutical compositions including hydrocodone bitartrate and guaifenesin Lapsed on the fee record Ended Dec 21, 2025 · From the USPTO record | Lapsed on the fee record | Ended Dec 21, 2025 | From the USPTO record |
| US 10,973,802 | Oral liquid compositions including valsartan Lapsed on the fee record Ended Apr 13, 2025 · From the USPTO record | Lapsed on the fee record | Ended Apr 13, 2025 | From the USPTO record |
| US 10,959,985 | Pharmaceutical compositions including carvedilol and methods of using the same Lapsed on the fee record Ended Mar 30, 2025 · From the USPTO record | Lapsed on the fee record | Ended Mar 30, 2025 | From the USPTO record |
| US 10,772,869 | Pharmaceutical compositions including carvedilol and methods of using the same Lapsed on the fee record Ended Sep 15, 2024 · From the USPTO record | Lapsed on the fee record | Ended Sep 15, 2024 | From the USPTO record |
| US 10,548,838 | Oral liquid compositions including valsartan Lapsed on the fee record Ended Feb 4, 2024 · From the USPTO record | Lapsed on the fee record | Ended Feb 4, 2024 | From the USPTO record |
| US 10,478,422 | Oral liquid compositions including valsartan Lapsed on the fee record Ended Nov 19, 2023 · From the USPTO record | Lapsed on the fee record | Ended Nov 19, 2023 | From the USPTO record |